Patel B G, Parsons C L, Bidair M, Schmidt J D
Division of Urology, UCSD Medical Center 92103-8897, USA.
J Surg Oncol. 1996 Dec;63(4):256-64. doi: 10.1002/(SICI)1096-9098(199612)63:4<256::AID-JSO8>3.0.CO;2-B.
Percutaneous transperineal cryoablation of the prostate is now available in the armamentarium for treatment of prostate cancer. Technical advances in real-time transrectal imaging of the prostate and improvements in cryosurgical equipment have brought this modality into the limelight of available prostate cancer management. Cryosurgery can be offered to many patients with prostate cancer. However, the main indications for its use include primary treatment for localized disease, salvage therapy after failure of traditional methods, and relief of local symptoms. A historical background, description of the technique, and clinical experience at several medical centers including the University of California San Diego, Allegheny General Hospital, University of Texas M.D. Anderson Cancer Center, and Crittenton Hospital, are presented.
经皮经会阴前列腺冷冻消融术现已成为治疗前列腺癌的可用手段。前列腺实时经直肠成像技术的进步以及冷冻手术设备的改进，使这种治疗方式在前列腺癌现有治疗手段中备受关注。许多前列腺癌患者都可以接受冷冻手术。然而，其主要应用指征包括局部疾病的初始治疗、传统方法治疗失败后的挽救性治疗以及缓解局部症状。本文介绍了包括加利福尼亚大学圣地亚哥分校、阿勒格尼综合医院、德克萨斯大学MD安德森癌症中心和克里滕顿医院在内的多家医学中心的历史背景、技术描述及临床经验。
